A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
it's a significant, sometimes dramatic shift in biological activity and stability, which makes understanding its dosing an absolutely critical, non-negotiable element of any valid research project
Exposure to a concentrated dose of environmental toxins or chronic low-level exposure to these toxic compounds can spark a process known as toxicant-induced loss of tolerance or TILT
Conformational changes on substrate binding to methyl malonyl CoA mutase and new insights into the free radical mechanism
alternative-therapies.com Regulatory, Anti Doping and Safety Sources FDA bulk drug substances safety risk list (BPC157 not approved)
Gold Winner, Employee Development Wolters Kluwer Tax & Accounting is named a Gold Winner for Employee Development by the Globee Awards